Over the past few years it has been recommended that emphasis be placed on the confidence interval rather than on hypothesis testing in the statistical analysis of medical data.'-3 Although the two methods approach the analysis and presentation of data differently and confidence intervals make assessment of results easier, differences in basic interpretation arise only in exceptional circumstances. One of the critical aspects of study design is to estimate the sample size required and, traditionally, such estimates are based on a hypothesis testing approach to data. Suppose a clinical trial is planned to compare an antihypertensive drug with a placebo and that suitable hypertensive patients are to be randomised into two equal sized groups. For simplicity, we assume the groups will have similar baseline blood pressures and that the treatment effect is to be evaluated by examining the difference in mean systolic blood pressure after a period of, say, six weeks.
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Confidence intervals versus p values
A large proportion of medical research concerns the comparison of two groups, each of which may be considered a sample from a larger population. A hypothesis testing approach to statistical analysis typically determines whether some appropriate comparative measure (such as the difference between means or a relative risk) is significantly different from its null value (for example, a mean difference of zero or a relative risk of one). A confidence interval approach, however, concentrates on an estimation of the comparative measure together with its confidence intervals. The confidence interval gives an indication of the degree of imprecision of the sample value as an estimate of the population value. It is important to note, however, that hypothesis testing and confidence intervals are intimately connected.4 Ifa 95% confidence interval does not include the null value ofthe hypothesis test then we can infer a statistically significant result at the two sided 5% level.
In this paper I consider the comparison of means by using a difference measure in the two group parallel design, but similar considerations apply to other comparative measures, studies of more than two groups, and within subjects designs such as crossover trials. The arguments in this paper are not germane, however, when the sole purpose of an investigation is to obtain an estimate for a non-comparative measure, as, for example, in a descriptive prevalence study in which no comparisons are planned. Such situations are rare and hypothesis tests are inappropriate.
Sample size and hypothesis tests One of the critical aspects of study design is to estimate the sample size required and, traditionally, such estimates are based on a hypothesis testing approach to data. Suppose a clinical trial is planned to compare an antihypertensive drug with a placebo and that suitable hypertensive patients are to be randomised into two equal sized groups. For simplicity, we assume the groups will have similar baseline blood pressures and that the treatment effect is to be evaluated by examining the difference in mean systolic blood pressure after a period of, say, six weeks.
To determine the sample size required for this trial several quantities must be considered5 6: * Firstly, the significance level (usually 5% or 1%) at which we wish to perform our hypothesis test and ifit is to be one tailed or two tailed. (Apart from in exceptional circumstances two tailed tests are usually more appropriate) * Secondly, the smallest clinically worthwhile difference in blood pressure we wish to detect. We must distinguish here between the blood pressure difference that we might observe in our study (the sample result) and the real treatment effect. The real treatment effect can be thought of as the difference in blood pressure that would be observed in a study so large that sample variation was precluded, or, alternatively, as the blood pressure difference between the "populations" of treated and untreated patients. If there was a real treatment effect of important size we would want our study to reflect this with a statistically significant result. We would be unlikely, however, to be interested in detecting a very small (real population) difference of, say, only 1 mm Hg as from a clinical point of view such a treatment effect could be considered negligible. We therefore decide on the smallest difference worth detecting such that if the real difference was this large or larger we would be likely to achieve a significant result; on the other hand, for real differences smaller than this a non-significant result is judged acceptable.7 In our trial the smallest clinically worthwhile difference might be set at 5 mm Hg * Thirdly, the power of the study. This is the chance of obtaining a significant result if the real effect is as great or greater than the smallest worthwhile difference specified. Powers 170 , its width would be 80.) All else being equal, the larger the sample size the narrower the width of the confidence interval. Once the width has been prespecified the only additional requirements for determination of a sample size by this approach are the confidence level (95% or 99%) and an estimate of the variability of the comparative measure. These specifications are clinically understandable and the difficult concepts of power, null value, and smallest difference to be detected seem to be avoided altogether. In addition, concentration on the precision of the estimate seems to fit in fully with an analysis that is to be performed with confidence intervals. Tables and formulas using this approach are available for various comparative measures.8" (A further refinement is to estimate sample sizes on the basis that the width of the confidence interval, rather than being fixed, is a percentage ofthe actual population value.89 12) Table II gives the sample size requirements in each group of our clinical trial to achieve confidence interval widths of 10, 20, or 30 mm Hg for the difference between the mean blood pressures (see appendix for computational details).
Confidence intervals and null values
Although the precision of any measure is very important, estimates of sample size based on the width of the confidence interval can be misleading. The consequences of employing such estimates do not seem clearly to be understood, and, in general, the published work does not consider the problems explicitly. One distinction between hypothesis tests and confidence intervals is important in this regard."''4 Hypothesis tests are essentially asymmetrical with the emphasis on rejection or non-rejection of the null hypothesis. Conversely, confidence intervals are symmetrical and estimate the magnitude of the difference between two groups without giving any special importance to the null value. It seems a mistake, however, to conclude that this null value is irrelevant to the interpretation of confidence intervals, even though it plays no part in their calculation. Irrespective of precision, there is a qualitative difference between a confidence interval that includes the null value and one that does not include it. If the null value is included the possibility of no difference must be accepted, while if it is not some difference has been shown at a given level of probability. Herein lies the crux of the problem. In a comparative study can we ever say that the primary goal is just estimation and ignore completely the qualitative distinction between a difference and no difference? The answer is clearly no, and I argue below that the null value must have a central role in the estimation of sample sizes with a confidence interval approach. This is not usually the case.
Confidence intervals, power, and worthwhile differences
The role of the smallest clinically worthwhile difference to be detected (as specified by the alternative hypothesis) has also been questioned in the context of sample sizes based on confidence intervals. overcomes the problem related to expected width discussed above but does not account for the true location of the parameter of interest. Sample sizes based on this approach are still much lower than traditional estimates.
In planning any investigation the question of power to detect the smallest clinically worthwhile difference must predominate over that of precision. In practice, of course, estimates based on samples large enough to detect small differences will have a high degree of precision. It is only when we are trying to detect large differences (not often found in medical research) that an imprecise estimate will result. In this situation it would in any case be possible to calculate a sample size based on precision also and use the larger of the two sizes so calculated. In line with this view, Bristol'4 gives tables and formulas relating to the width of the interval to the power for detecting various alternatives when comparing differences of means and proportions. However, if these factors have to be considered at all, why should estimates of sample size not explicitly specify power to detect the smallest worthwhile difference in the first place, rather than concealing the specification in a vaguer requirement for confidence interval precision?
Confidence intervals and standard sample size tables I propose that sample size requirements, which explicitly consider power, null values, and smallest worthwhile differences, can easily be put into a confidence interval framework without the consideration of hypothesis tests in either design or analysis. Although discussion has been in the context ofemploying the difference between means as a comparative measure, this proposal has general applicability. For a calculation of sample size based on confidence intervals we should specify (a) the confidence level (95% or 99%), (b) the minimum size of the comparative measure we wish to estimate unambiguously (that is, with the confidence interval excluding the null value), (c) the chance of achieving this if the measure actually had this minimum value (in the population). These correspond, of course, to the traditional requirements of (a) the significance level, (b) the smallest worthwhile difference to be detected, (c) the power of the study. Thus with only a slight change of wording the standard procedures based on hypothesis testing can be used to estimate sample sizes in the context of a confidence interval analysis.
It is essential to note that this approach allows for the sampling variability of both the location and width of the confidence interval. The width of the interval, however, is not explicitly prespecified; it is instead determined by the more important criterion that we are unlikely to miss a difference we wish to detect.
Greenland comes nearest to this view in terms of confidence intervals and sample size.'3 The proposal outlined in this paper is based on distinguishing between a particular difference, if its exists, and the null value. Greenland, however, in a subtle modification of this approach, also suggests that the sample size should be large enough to distinguish between the null value and this difference, if the groups are the same. In most situations this extra requirement does not result in an increase of sample size and it seems an unnecessary refinement. A further proposal by Greenland, which greatly increases sample size requirements calculated with confidence intervals, is based on unnecessarily stringent criteria.
Conclusion
There is no doubt that the whole topic of traditional sample size calculation tends to be complex and misunderstood and, even today, many studies are carried out without computing the necessary numbers.'7 1 Estimating an appropriate sample size is a vital part of any research design, and it is important that the current emphasis on using confidence intervals in analysis and presentation does not mislead researchers to employ samples sizes based on the width of confidence intervals. Though apparently much simpler, such calculations can result in studies too small to achieve meaningful results.
Examination of precision may well be a useful adjunct to traditional estimation of sample size, but unless we place our primary emphasis on the question of power to detect an appropriate effect we could be making a serious mistake. The use of confidence intervals in analysis, however, must be encouraged, and this paper indicates how a realistic rewording of the usual specifications allows standard approaches to be used for calculations of sample size in a confidence interval framework.
There is no need to throw out our old sample size tables in this era of confidence intervals. In fact, we should guard them with care. Inadequate sample size has been a major problem in medical research, and we do not want to repeat those mistakes in the future. According to Altman: "However praiseworthy a study may be from other points of view, if the statistical aspects are substandard then the research will be unethical."'9 If we depart from the tried and tested approach for calculations of sample size we are in danger of disregarding this principle.
I thank the referees of this paper for valuable advice.
Appendix
This appendix gives the formulas on which the sample size calculations in this paper are based. The following notation is used, with significance, confidence, and power levels expressed as proportions n= Sample size in each of the two groups G=Population standard deviation (assumed equal in the two groups) A= Smallest worthwhile difference to be detected 
A2
Expected confidence interval for the difference between means (using normal approximation):
XlX-R2±Zl-(2 o\V(2/n) (Note that the actual confidence interval for a given set of study data would use the sample standard deviation rather than a and the appropriate critical value of the Student's t distribution rather than Z1 -(L2)-Expected width of confidence interval:
w=2 Z1-(2 oV(2/n) A basic tenet, it seems, is that it is the high state of anxiety in autism that blocks learning. Put in different words this is the tenet of many approaches to autism-that attempts to insist on the child interrelating (whether this be for learning or for socialisation) result in anxiety and avoidance. "Holding therapy" is one approach to the problem; low intensity persistent firmness is another. At this school, which clearly employs the second to the extremes of patience in the staff, a new approach is added: physical activities to reduce anxiety levels.
So it seems that the school's programme is a mixture of these two, about half the child's day being spent in sports and other physical activities and half in more formal learning (with a short time in the dormitories at night which is less structured). The atmosphere conveyed in the programme was not alarming -it seemed to be warm and caring, with staff showing great persistence and patience. Their input was enormous and one can understand the size of fees (£30 000 a year) as very high staffing levels must be needed. The school houses 88 children, all boarders.
The programme traced two British children, Ruth, aged 3, and Joseph, aged 8, in particular, with some reference to a third British child, John. We saw the enormous strain on the parents of Ruth and the distress that Joseph's behaviour caused to his parents. Insufficient detail and history were given to be able to say for sure whether they have classic primary autism, but their behaviours suggested this. We saw them at home, on arrival at the school and at the separation between parents and children, the children's involvement in some aspects of the programme at the school, and then the parents and children on reunion four months later.
The changes, as filmed by the crew, were impressive as was the obvious satisfaction of the parents. The children handled the reunion in a calm and socialised manner and the outing for a hamburger was remarkably contained. Clearly, considerable changes had been achieved in behaviour.
The 
